Abstract
BACKGROUND/OBJECTIVES
Curcumin is a well-known phytochemical with anti-inflammatory effects. Heat shock protein (HSP) 70, an intracellular chaperone, inhibits proinflammatory signaling activation. Although curcumin has been shown to induce HSP70 expression in various cell types, whether HSP70 mediates the anti-inflammatory effects of curcumin in mature adipocytes remains unclear.
MATERIALS/METHODS
To assess the role of HSP70 in regulating the anti-inflammatory response to curcumin in adipocytes, fully differentiated 3T3-L1 adipocytes were treated with curcumin, lipopolysaccharide (LPS), and/or the HSP70 inhibitor pifithrin-μ (PFT-μ). The expression levels of HSP70 and proinflammatory cytokines were then measured.
RESULTS
Curcumin upregulated HSP70 expression at both protein and mRNA levels and attenuated LPS-induced Il6, Ptx3, and Ccl2 mRNA upregulation. PFT-μ tended to exacerbate the LPS-induced upregulation of Il6, Ptx3, Ccl2, and Tnfa mRNA expression. However, on curcumin pretreatment, the tendency of PFT-μ to upregulate LPS-induced proinflammatory cytokine expression decreased or disappeared.
Systemic chronic inflammation is strongly linked to the development of diabetes, cardiovascular diseases, neurodegenerative diseases, and multiple types of cancers [1]. Inflammation-associated chronic diseases are estimated to account for approximately 63% of all-cause mortality worldwide [2]. Nutritional factors, such as the quantity of overall dietary intake and specific nutrients or phytochemicals, have been identified as causes or suppressors of chronic inflammation [2]. Many previous studies have reported that excessive dietary intake or the intake of saturated fatty acids can induce inflammation and result in metabolic stress [3]; however, phytochemicals, which provide color, flavor, smell, texture, and other sense-engaging properties to plants [4], exert health beneficial effects by reducing the incidence of inflammation-associated chronic diseases in humans and various animal models [5].
Curcumin, a phenolic acid isolated from the herb Curcuma longa [5], is a well-known phytochemical with anti-inflammatory effects [6]. It has been found to downregulate the production of diverse proinflammatory cytokines, including tumor necrosis factor (TNF)-α, monocyte chemotactic protein (MCP)-1, and interleukin (IL)-6, by suppressing nuclear factor kappa-B (NF-κB) activation [67]. The anti-inflammatory effects of curcumin contribute to the prevention of metabolic dysregulation [8]. In multiple clinical trials, curcumin supplementation has been found to improve metabolic parameters, including fasting glucose and insulin, serum triacylglycerol (TAG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) levels [91011].
On the other hand, curcumin has been reported to increase the expression of heat shock protein (HSP) 70 in various cell types, including carcinoma, leukemia, and epithelial cells [121314]. HSP70 is involved in the regulation of cellular responses to inflammatory conditions [151617]. As a ribosome-associated chaperone, HSP70 controls unfolded protein response and endoplasmic reticulum stress [15]. Moreover, as an inhibitor of NF-κB essential modulator, HSP70 suppresses NF-κB signaling activation by inhibiting the phosphorylation of inhibitory κB (IκB) and nuclear translocation of NF-κB, thereby downregulating the expression of proinflammatory cytokines [161718].
Although curcumin is one of the most investigated phytochemicals in terms of its anti-inflammatory effects and underlying mechanisms, whether curcumin upregulates the expression of HSP70 in mature adipocytes and whether the induction of HSP70 is crucial for regulating the anti-inflammatory response of mature adipocytes to curcumin remain unclear. Therefore, this study aimed to assess the role of HSP70 in regulating the effects of curcumin on NF-κB signaling and inflammation using fully differentiated 3T3-L1 adipocytes.
3T3-L1 fibroblasts (American Type Culture Collection, Manassas, VA, USA) were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 4,500 mg/L glucose and L-glutamine (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% bovine calf serum (Corning, Corning, NY, USA) and 1% antibiotic antimycotic solution at 37°C in the presence of 5% CO2. Two days after confluence, adipogenic differentiation was initiated using DMEM with 10% fetal bovine serum, 1.7 μM insulin, 1 μM dexamethasone, and 500 μM 3-isobutyl-1-methylxanthine (Sigma-Aldrich). After 2 days, the medium was changed to DMEM with 10% FBS and 1.7 μM insulin. After another 2 days, the medium was changed to DMEM with 10% FBS. When the cells had a spherical shape and were filled with lipid droplets, they were considered fully differentiated.
As previous studies have reported that curcumin concentrations ≤ 100 μM do not induce cell toxicity in adipocytes or adipose-derived mesenchymal stem cells [1920], fully differentiated 3T3-L1 adipocytes were pretreated with 0.1–100 μM curcumin (Cayman, Ann Arbor, MI, USA) dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) for 24 h. The control was pretreated with DMSO. After curcumin or DMSO pretreatment, the cells were treated with 10 μg/mL lipopolysaccharide (LPS; Sigma-Aldrich) for 30 min or 3 h and/or 1 μM pifithrin-μ (PFT-μ, HSP70 inhibitor; Cayman) for 24 h.
Proteins were extracted from 3T3-L1 adipocytes using RIPA lysis buffer containing a protease inhibitor cocktail (Sigma-Aldrich), phenylmethylsulfonyl fluoride, and Na3VO4. The protein concentration was determined using a bicinchoninic acid assay (Sigma-Aldrich). Protein lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. After blocking, the membrane was incubated with rabbit anti-HSP70, rabbit anti-p-IκB, rabbit anti-IκB, and mouse anti-β-actin (Cell Signaling, Danvers, MA, USA). Following this, the membrane was incubated with horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit IgG (Cell Signaling) and imaged using Immobilon Western Chemiluminescent HRP Substrate (Millipore, Burlington, MA, USA). The band density was normalized relative to that of β-actin.
Total RNA was extracted from 3T3-L1 cells using TRIzol (Ambion, Austin, TX, USA) and reverse transcribed to cDNA using M-MLV reverse transcriptase (Promega, Madison, WI, USA). Quantitative real-time PCR was performed on a Bio-Rad iQ5 system (Bio-Rad, Hercules, CA, USA) using RT2 SYBR Green Fluor qPCR Mastermix (Qiagen, Valencia, CA, USA). The mRNA levels of Hspa1a, Nfkb1, Il6, Ptx3, Ccl2, and Tnfa were quantified and normalized relative to those of 18S rRNA. Fold changes in gene expression were calculated using the ΔΔCt method. Specific primer sequences used are shown in Table 1.
18S, 18S ribosomal RNA; Hspa1a, heat shock protein family A (heat shock protein 70) member 1A; Nfkb1, nuclear factor kappa B subunit 1; Il6, interleukin 6; Ptx3, pentraxin 3 (also known as tumor necrosis factor-inducible gene 14 protein); Ccl2, C-C motif chemokine ligand 2 (also known as monocyte chemoattractant protein-1); Tnfa, tumor necrosis factor α.
One-way or 2-way analysis of variance with Duncan’s post hoc test was performed to determine significant differences induced by treatment with curcumin, LPS, and/or PFT-μ. Data are presented as the means ± standard error of means and were analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Differences were considered statistically significant at P < 0.05.
To determine whether curcumin induces HSPs, fully differentiated 3T3-L1 adipocytes were treated with 0.1–100 μM curcumin for 24 h. Curcumin upregulated the level of HSP70 in a dose-dependent manner, and its effects on HSP70 induction were significant at 100 μM (Fig. 1A). Although 75 μM curcumin did not have a significant effect on HSP70 induction, more consistent upregulation of HSP70 was noted on treatment with 75 μM curcumin than on treatment with 100 μM curcumin (data not shown). Therefore, 75 μM curcumin was used for treatment in subsequent experiments. On the other hand, curcumin did not affect HSP90 expression (Fig. 1B).
When 3T3-L1 adipocytes pretreated with 75 μM curcumin were treated with 10 μg/mL LPS for 30 min, the curcumin-induced upregulation of HSP70 expression decreased (Fig. 2A). LPS treatment increased the phosphorylation (P = 0.011; Fig. 2B) and degradation (P = 0.050; Fig. 2C) of IκB. Curcumin-pretreated cells tended to have a higher level of IκB (P = 0.079; Fig. 2C).
To determine the effects of curcumin and LPS on NF-κB target gene expression, 3T3-L1 adipocytes pretreated with 75 μM curcumin were treated with 10 μg/mL LPS for 3 h. As the nuclear translocation of NF-κB and transcription of NF-κB target genes take time after IκB phosphorylation and degradation, the cells were treated with LPS for longer in this experiment. Curcumin upregulated the mRNA expression of the HSP70-encoding gene Hspa1a; however, LPS did not suppress this upregulated gene expression. LPS tended to upregulate the mRNA expression of Nfkb1 (P = 0.058), and curcumin pretreatment suppressed the LPS-induced upregulation of NF-κB target genes, including Il6, Ptx3, and Ccl2, at the mRNA level (Fig. 3).
To determine whether HSP70 induction is crucial for the anti-inflammatory effects of curcumin in 3T3-L1 adipocytes, cells were co-treated with 1 μM of the HSP70 inhibitor PFT-μ and 10 μg/mL LPS after pretreatment with 75 μM curcumin. The cells co-treated with PFT-μ and LPS tended to have higher mRNA expression levels of Il6, Ptx3, Ccl2, and Tnfa than those treated with LPS only. However, no effect of PFT-μ was noted in the curcumin-pretreated cells (Fig. 4).
As it is possible that the effects of curcumin were too strong and masked the effects of PFT-μ on HSP70 inhibition, a similar experiment was conducted using a lower concentration of curcumin (7.5 μM). Although the difference was not statistically significant, in the cells pretreated with 7.5 μM curcumin, PFT-μ and LPS co-treatment resulted in slightly higher mRNA expression levels of Il6 and Ptx3 than LPS treatment only (Fig. 5).
In this study, curcumin was found to suppress the expression of LPS-induced proinflammatory cytokines in fully differentiated 3T3-L1 adipocytes. The anti-inflammatory effects of curcumin have been reported in various experimental models and humans [72122232425]. In 3T3-L1 murine adipocytes, curcumin suppressed the TNF-α-induced upregulation of Il1b, Il6, and Tnfa mRNA expression [7]. In diet-induced or genetically obese mice, curcumin reduced macrophage infiltration in the white adipose tissue and NF-κB activity in the liver [2122]. In an atherosclerotic mouse model, curcumin administration alleviated atherosclerotic lesions; lowered plasma cholesterol, TAG, and LDL levels; and increased the HDL level [23]. In prediabetic or type 2 diabetic patients, curcumin intervention lowered fasting blood glucose, glycated hemoglobin, serum nonesterified fatty acid, and serum TAG levels and improved pancreatic β-cell function [2425]. These data indicate that the anti-inflammatory effects of curcumin can lower the risk of atherosclerosis and insulin resistance.
Curcumin specifically upregulated HSP70 expression at both mRNA and protein levels in 3T3-L1 adipocytes. The expression level of HSP70 was found to be negatively correlated with the degree of inflammation [26], and HSP70 induction by drugs ameliorated symptoms of inflammatory diseases in animal models [2728]. Patients with steatohepatitis and fibrosis had lower levels of HSP70 and HSF1, a transcription factor of HSP70, in the visceral adipose tissue and liver than those with steatosis [26]. Geranylgeranylacetone, an HSP70-inducing drug, could recover the HSP70 level and HSF1 induction and improve the glucose clearance rate in diabetic monkeys [27]. In addition, 17-allylamino-demethoxygeldanamycin, another HSP70-inducing drug, increased neuronal survival and reduced brain edema in rats with brain injury [28].
Although LPS treatment for 30 min downregulated the protein expression level of HSP70, LPS treatment for 3 h did not change the mRNA expression level of Hspa1a. As HSP70 protein levels were found to be positively correlated with Hspa1a mRNA levels in multiple studies that assessed HSP70 expression at both protein and mRNA levels [2930], this inconsistency may be attributed to the difference in treatment times. LPS treatment for more than 60 min was found to upregulate HSP70 expression in various in vitro models [313233]. LPS activated HSF1 by phosphorylation within 5 min of treatment; this effect persisted for 30 min and returned to baseline by 60 min [33].
To determine the role of HSP70 inhibition in the anti-inflammatory response of 3T3-L1 adipocytes to curcumin, cells were co-treated with PFT-μ and LPS after curcumin pretreatment. PFT-μ is known to inhibit HSP70 by disrupting the association between HSP70 and its substrate proteins [34]. To determine the optimal concentration, curcumin-pretreated 3T3-L1 adipocytes were treated with 0.1–200 μM PFT-μ (Supplementary Fig. 1). Compared with other concentrations, 1 μM PFT-μ slightly upregulated the mRNA expression of Hspa1a (albeit not significantly so) and significantly augmented the LPS-induced mRNA upregulation of Ccl2. Therefore, 1 μM PFT-μ was used for HSP70 inhibition in subsequent experiments.
When 3T3-L1 adipocytes were not pretreated with curcumin or were pretreated with a very low concentration of curcumin (7.5 μM), treatment with 1 μM PFT-μ tended to augment the LPS-induced upregulation of proinflammatory cytokine-encoding genes, including Il6, Ptx3, and Ccl2; however, it did not alter the mRNA expression of Hspa1a. Previous studies have reported inconsistent data about the effects of PFT-μ on HSP70 expression [3536]. The expression of HSP70 was upregulated by 40 μM PFT-μ [35] but not by 8 μM PFT-μ [36]; however, both concentrations of PFT-μ significantly increased cell apoptosis, which is mediated by HSP70 inhibition. These results suggest that a low concentration of PFT-μ is enough to inhibit HSP70.
Although HSP70 inhibition by PFT-μ did not significantly reverse the anti-inflammatory effects of curcumin (75 μM) in this study, previous studies have reported that the genetic suppression of Hspa1a or Hsf1 could reduce the anti-inflammatory effects of other phytochemicals. Celastrol, a triterpenoid quinone methide present in thunder god vine root extracts, could upregulate the expression level of HSP70 in a time- and dose-dependent manner [37], while Hspa1a siRNA could reverse the celastrol-induced downregulation of NF-κB p65 DNA-binding activity and IL-6 secretion in human retinal pigment epithelial cells [38]. Zerumbone, a sesquiterpene present in subtropical ginger, also induced HSP70 expression in a dose-dependent manner [39], and Hsf1 siRNA reversed the zerumbone-induced downregulation of Il1b and Nos2 mRNA expression in RAW 264.7 macrophages [40]. These data indicate that HSP70 induction is crucial for the anti-inflammatory effects of celastrol and zerumbone.
A limitation of this study is that the effect of PFT-μ on the disruption of HSP70 binding to its substrate proteins was not determined. Moreover, to reach a strong conclusion, it would be helpful to assess the expression of the markers at both mRNA and protein levels, to increase the number of replicates of the experiments, or to include a positive control, such as HSP70-inducing drugs. However, despite these limitations, this study provides some novel evidence regarding the necessity of HSP70 for the anti-inflammatory effects of curcumin in mature adipocytes.
In summary, curcumin upregulated the expression of HSP70 and attenuated the LPS-induced upregulation of proinflammatory cytokine-encoding genes in fully differentiated 3T3-L1 adipocytes; however, the inhibition of HSP70 by PFT-μ did not significantly curb the anti-inflammatory effects of curcumin. This implies that HSP70 induction, involved in the regulation of anti-inflammatory responses, may not be the main mechanism by which curcumin exerts its anti-inflammatory effects. However, based on the results of previous studies [3840], it is still possible that the genetic suppression of HSP70 expression could reduce the effects of curcumin. Therefore, additional studies with Hspa1a knockdown or knockout are warranted to clarify the role of HSP70 in the regulation of the anti-inflammatory effects of curcumin.
References
1. Pan MH, Lai CS, Dushenkov S, Ho CT. Modulation of inflammatory genes by natural dietary bioactive compounds. J Agric Food Chem. 2009; 57:4467–4477. PMID: 19489612.
2. Prasad S, Aggarwal B. Chronic diseases caused by chronic inflammation require chronic treatment: anti-inflammatory role of dietary spices. J Clin Cell Immunol. 2014; 5:238.
3. Afman L, Milenkovic D, Roche HM. Nutritional aspects of metabolic inflammation in relation to health--insights from transcriptomic biomarkers in PBMC of fatty acids and polyphenols. Mol Nutr Food Res. 2014; 58:1708–1720. PMID: 24449395.
4. Son TG, Camandola S, Mattson MP. Hormetic dietary phytochemicals. Neuromolecular Med. 2008; 10:236–246. PMID: 18543123.
5. Si H, Liu D. Dietary antiaging phytochemicals and mechanisms associated with prolonged survival. J Nutr Biochem. 2014; 25:581–591. PMID: 24742470.
6. Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011; 50:151–161. PMID: 21442412.
7. Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond). 2008; 5:17. PMID: 18549505.
8. Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Curcumin in metabolic health and disease. Nutrients. 2021; 13:4440. PMID: 34959992.
9. Jalali M, Mahmoodi M, Mosallanezhad Z, Jalali R, Imanieh MH, Moosavian SP. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020; 48:102283. PMID: 31987259.
10. Chien YJ, Chang CY, Wu MY, Chen CH, Horng YS, Wu HC. Effects of curcumin on glycemic control and lipid profile in polycystic ovary syndrome: systematic review with meta-analysis and trial sequential analysis. Nutrients. 2021; 13:684. PMID: 33669954.
11. Wickenberg J, Ingemansson SL, Hlebowicz J. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Nutr J. 2010; 9:43. PMID: 20937162.
12. Chen YC, Tsai SH, Shen SC, Lin JK, Lee WR. Alternative activation of extracellular signal-regulated protein kinases in curcumin and arsenite-induced HSP70 gene expression in human colorectal carcinoma cells. Eur J Cell Biol. 2001; 80:213–221. PMID: 11322385.
13. Teiten MH, Reuter S, Schmucker S, Dicato M, Diederich M. Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett. 2009; 279:145–154. PMID: 19246153.
14. Guo M, Xu W, Yamamoto Y, Suzuki T. Curcumin increases heat shock protein 70 expression via different signaling pathways in intestinal epithelial cells. Arch Biochem Biophys. 2021; 707:108938. PMID: 34051214.
15. Wang J, Lee J, Liem D, Ping P. HSPA5 gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum. Gene. 2017; 618:14–23. PMID: 28286085.
16. Kim JY, Yenari MA. The immune modulating properties of the heat shock proteins after brain injury. Anat Cell Biol. 2013; 46:1–7. PMID: 23560231.
17. Ran R, Lu A, Zhang L, Tang Y, Zhu H, Xu H, Feng Y, Han C, Zhou G, Rigby AC, et al. Hsp70 promotes TNF-mediated apoptosis by binding IKKγ and impairing NF-κB survival signaling. Genes Dev. 2004; 18:1466–1481. PMID: 15198984.
18. Ferat-Osorio E, Sánchez-Anaya A, Gutiérrez-Mendoza M, Boscó-Gárate I, Wong-Baeza I, Pastelin-Palacios R, Pedraza-Alva G, Bonifaz LC, Cortés-Reynosa P, Pérez-Salazar E, et al. Heat shock protein 70 down-regulates the production of toll-like receptor-induced pro-inflammatory cytokines by a heat shock factor-1/constitutive heat shock element-binding factor-dependent mechanism. J Inflamm (Lond). 2014; 11:19. PMID: 25053922.
19. Green A, Krause J, Rumberger JM. Curcumin is a direct inhibitor of glucose transport in adipocytes. Phytomedicine. 2014; 21:118–122. PMID: 24060216.
20. Wang N, Wang F, Gao Y, Yin P, Pan C, Liu W, Zhou Z, Wang J. Curcumin protects human adipose-derived mesenchymal stem cells against oxidative stress-induced inhibition of osteogenesis. J Pharmacol Sci. 2016; 132:192–200. PMID: 27840063.
21. Weisberg SP, Leibel R, Tortoriello DV. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology. 2008; 149:3549–3558. PMID: 18403477.
22. Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, Lu H, Fantus IG, Jin T. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 2012; 7:e28784. PMID: 22253696.
23. Shin SK, Ha TY, McGregor RA, Choi MS. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res. 2011; 55:1829–1840. PMID: 22058071.
24. Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, Li XX, Sun CH. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res. 2013; 57:1569–1577. PMID: 22930403.
25. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012; 35:2121–2127. PMID: 22773702.
26. Di Naso FC, Porto RR, Fillmann HS, Maggioni L, Padoin AV, Ramos RJ, Mottin CC, Bittencourt A, Marroni NA, de Bittencourt PI Jr. Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. Obesity (Silver Spring). 2015; 23:120–129. PMID: 25292174.
27. Kavanagh K, Flynn DM, Jenkins KA, Zhang L, Wagner JD. Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys. Am J Physiol Endocrinol Metab. 2011; 300:E894–E901. PMID: 21325107.
28. Gu Y, Chen J, Wang T, Zhou C, Liu Z, Ma L. Hsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injury. Exp Ther Med. 2016; 12:3767–3772. PMID: 28101166.
29. Tulapurkar ME, Ramarathnam A, Hasday JD, Singh IS. Bacterial lipopolysaccharide augments febrile-range hyperthermia-induced heat shock protein 70 expression and extracellular release in human THP1 cells. PLoS One. 2015; 10:e0118010. PMID: 25659128.
30. Zhang Y, Ma X, Jiang D, Chen J, Jia H, Wu Z, Kim IH, Yang Y. Glycine attenuates lipopolysaccharide-induced acute lung injury by regulating NLRP3 inflammasome and NRF2 signaling. Nutrients. 2020; 12:611. PMID: 32110933.
31. Bernardini C, Zannoni A, Turba ME, Fantinati P, Tamanini C, Bacci ML, Forni M. Heat shock protein 70, heat shock protein 32, and vascular endothelial growth factor production and their effects on lipopolysaccharide-induced apoptosis in porcine aortic endothelial cells. Cell Stress Chaperones. 2005; 10:340–348. PMID: 16333987.
32. Wu S, Yano S, Chen J, Hisanaga A, Sakao K, He X, He J, Hou DX. Polyphenols from Lonicera caerulea L. berry inhibit LPS-induced inflammation through dual modulation of inflammatory and antioxidant mediators. J Agric Food Chem. 2017; 65:5133–5141. PMID: 28573848.
33. Gupta A, Cooper ZA, Tulapurkar ME, Potla R, Maity T, Hasday JD, Singh IS. Toll-like receptor agonists and febrile range hyperthermia synergize to induce heat shock protein 70 expression and extracellular release. J Biol Chem. 2013; 288:2756–2766. PMID: 23212905.
34. Leu JI, Pimkina J, Frank A, Murphy ME, George DL. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell. 2009; 36:15–27. PMID: 19818706.
35. Ishaq M, Ojha R, Sharma K, Sharma G, Singh SK, Majumdar S. Functional inhibition of Hsp70 by pifithrin-μ switches Gambogic acid induced caspase dependent cell death to caspase independent cell death in human bladder cancer cells. Biochim Biophys Acta. 2016; 1863:2560–2573. PMID: 27395830.
36. Sheng L, Tang T, Liu Y, Ma Y, Wang Z, Tao H, Zhang Y, Qi Z. Inducible HSP70 antagonizes cisplatin\xe2\x80\x91induced cell apoptosis through inhibition of the MAPK signaling pathway in HGC\xe2\x80\x9127 cells. Int J Mol Med. 2018; 42:2089–2097. PMID: 30066840.
37. Salminen A, Lehtonen M, Paimela T, Kaarniranta K. Celastrol: molecular targets of thunder god vine. Biochem Biophys Res Commun. 2010; 394:439–442. PMID: 20226165.
38. Paimela T, Hyttinen JM, Viiri J, Ryhänen T, Karjalainen RO, Salminen A, Kaarniranta K. Celastrol regulates innate immunity response via NF-κB and Hsp70 in human retinal pigment epithelial cells. Pharmacol Res. 2011; 64:501–508. PMID: 21683142.
39. Ohnishi K, Nakahata E, Irie K, Murakami A. Zerumbone, an electrophilic sesquiterpene, induces cellular proteo-stress leading to activation of ubiquitin-proteasome system and autophagy. Biochem Biophys Res Commun. 2013; 430:616–622. PMID: 23219816.
40. Igarashi Y, Ohnishi K, Irie K, Murakami A. Possible contribution of zerumbone-induced proteo-stress to its anti-inflammatory functions via the activation of heat shock factor 1. PLoS One. 2016; 11:e0161282. PMID: 27536885.